Microdeletion 20p12.3 involving BMP2 contributes to syndromic forms of cleft palate

American Journal of Medical Genetics, Part A

Volumn 155, Issue 7, 2011, Pages 1646-1653

  Sahoo, Trilochan ^a   Theisen, Aaron ^a   Sanchez Lara, Pedro A ^b,c   Marble, Michael ^d,e   Schweitzer, Daniela N ^b   Torchia, Beth S ^a   Lamb, Allen N ^a   Bejjani, Bassem A ^a   Shaffer, Lisa G ^a   Lacassie, Yves ^d,e  

^a Signature Genomics   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c CHILDREN S HOSPITAL LOS ANGELES   (United States)

^d LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^e CHILDREN S HOSPITAL   (United States)

Author keywords

20p12.3; BMP2; Cleft palate; Microdeletion; Wolff Parkinson White syndrome

Indexed keywords

DNA;

ARTICLE; BMP2 GENE; BONE MORPHOGENETIC PROTEIN 2 GENE; CASE REPORT; CAUCASIAN; CHILD; CHROMOSOME 20P12.3 DELETION; CHROMOSOME DELETION; CHROMOSOME SIZE; CLEFT PALATE; CLINICAL FEATURE; DNA MICROARRAY; FACE DYSMORPHIA; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE; GENE DELETION; HEAD CIRCUMFERENCE; HUMAN; INFANT; MULTIGENE FAMILY; PATIENT REFERRAL; PIERRE ROBIN SYNDROME; PRIORITY JOURNAL; SCHOOL CHILD;

BONE MORPHOGENETIC PROTEIN 2; CHILD; CHILD, PRESCHOOL; CHROMOSOME DELETION; CHROMOSOMES, HUMAN, PAIR 20; CLEFT PALATE; FEMALE; GENETIC ASSOCIATION STUDIES; HUMANS; INFANT; INFANT, NEWBORN; MALE; PEDIGREE; PHENOTYPE; SYNDROME;

EID: 79959532631     PISSN: 15524825     EISSN: 15524833     Source Type: Journal    
DOI: 10.1002/ajmg.a.34063     Document Type: Article

References (29)

1. Abu-Issa R, Smyth G, Smoak I, Yamamura K, Meyers EN. 2002. Fgf8 is required for pharyngeal arch and cardiovascular development in the mouse. Development 129: 4613-4625.
2. Ballif BC, Theisen A, Coppinger J, Gowans GC, Hersh JH, Madan-Khetarpal S, Schmidt KR, Tervo R, Escobar LF, Friedrich CA, McDonald M, Campbell L, Ming JE, Zackai EH, Bejjani BA, Shaffer LG. 2008a. Expanding the clinical phenotype of the 3q29 microdeletion syndrome and characterization of the reciprocal microduplication. Mol Cytogenet 1: 8.
3. Ballif BC, Theisen A, McDonald-McGinn DM, Zackai EH, Hersh JH, Bejjani BA, Shaffer LG. 2008b. Identification of a previously unrecognized microdeletion syndrome of 16q11.2q12.2. Clin Genet 74: 469-475.
4. Dudas M, Sridurongrit S, Nagy A, Okazaki K, Kaartinen V. 2004. Craniofacial defects in mice lacking BMP type I receptor Alk2 in neural crest cells. Mech Dev 121: 173-182.
5. Duker AL, Ballif BC, Bawle EV, Person RE, Mahadevan S, Alliman S, Thompson R, Traylor R, Bejjani BA, Shaffer LG, Rosenfeld JA, Lamb AN, Sahoo T. 2010. Paternally inherited microdeletion at 15q11.2 confirms a significant role for the SNORD116C/D box snoRNA cluster in Prader-Willi syndrome. Eur J Hum Genet 18: 1196-1201.
6. Gorlin RJ, Cohen MM, Levin LS. 2001. Syndromes of the head and neck. New York: Oxford University Press.
7. Jugessur A, Farlie PG, Kilpatrick N. 2009. The genetics of isolated orofacial clefts: from genotypes to subphenotypes. Oral Dis 15: 437-453.
8. Kamath BM, Thiel BD, Gai X, Conlin LK, Munoz PS, Glessner J, Clark D, Warthen DM, Shaikh TH, Mihci E, Piccoli DA, Grant SF, Hakonarson H, Krantz ID, Spinner NB. 2009. SNP array mapping of chromosome 20p deletions: genotypes, phenotypes, and copy number variation. Hum Mutat 30: 371-378.
9. Kishigami S, Mishina Y. 2005. BMP signaling and early embryonic patterning. Cytokine Growth Factor Rev 16: 265-278.
10. Kugimiya F, Kawaguchi H, Kamekura S, Chikuda H, Ohba S, Yano F, Ogata N, Katagiri T, Harada Y, Azuma Y, Nakamura K, Chung UI. 2005. Involvement of endogenous bone morphogenetic protein (BMP) 2 and BMP6 in bone formation. J Biol Chem 280: 35704-35712.
11. Lalani SR, Thakuria JV, Cox GF, Wang X, Bi W, Bray MS, Shaw C, Cheung SW, Chinault AC, Boggs BA, Ou Z, Brundage EK, Lupski JR, Gentile J, Waisbren S, Pursley A, Ma L, Khajavi M, Zapata G, Friedman R, Kim JJ, Towbin JA, Stankiewicz P, Schnittger S, Hansmann I, Ai T, Sood S, Wehrens XH, Martin JF, Belmont JW, Potocki L. 2009. 20p12.3 microdeletion predisposes to Wolff-Parkinson-White syndrome with variable neurocognitive deficits. J Med Genet 46: 168-175.
12. Le Gloan L, Pichon O, Isidor B, Boceno M, Rival JM, David A, Le Caignec C. 2008. A 8.26Mb deletion in 6q16 and a 4.95Mb deletion in 20p12 including JAG1 and BMP2 in a patient with Alagille syndrome and Wolff-Parkinson-White syndrome. Eur J Med Genet 51: 651-657.
13. Liu W, Sun X, Braut A, Mishina Y, Behringer RR, Mina M, Martin JF. 2005. Distinct functions for Bmp signaling in lip and palate fusion in mice. Development 132: 1453-1461.
14. Lu H, Jin Y, Tipoe GL. 2000. Alteration in the expression of bone morphogenetic protein-2, 3, 4, 5 mRNA during pathogenesis of cleft palate in BALB/c mice. Arch Oral Biol 45: 133-140.
15. Ma L, Lu MF, Schwartz RJ, Martin JF. 2005. Bmp2 is essential for cardiac cushion epithelial-mesenchymal transition and myocardial patterning. Development 132: 5601-5611.
16. Meng L, Bian Z, Torensma R, Von den Hoff JW. 2009. Biological mechanisms in palatogenesis and cleft palate. J Dent Res 88: 22-33.
17. Nie X, Luukko K, Kettunen P. 2006. FGF signalling in craniofacial development and developmental disorders. Oral Dis 12: 102-111.
18. Nie XG. 2005. [Differential expression of Bmp2, Bmp4 and Bmp3 in embryonic development of mouse anterior and posterior palate.]. Chin Med J (Engl) 118: 1710-1716.
19. Nieminen P, Kotilainen J, Aalto Y, Knuutila S, Pirinen S, Thesleff I. 2003. MSX1 gene is deleted in Wolf-Hirschhorn syndrome patients with oligodontia. J Dent Res 82: 1013-1017.
20. Osoegawa K, Vessere GM, Utami KH, Mansilla MA, Johnson MK, Riley BM, L'Heureux J, Pfundt R, Staaf J, van der Vliet WA, Lidral AC, Schoenmakers EF, Borg A, Schutte BC, Lammer EJ, Murray JC, de Jong PJ. 2008. Identification of novel candidate genes associated with cleft lip and palate using array comparative genomic hybridisation. J Med Genet 45: 81-86.
21. Robert ML, Lopez T, Crolla J, Huang S, Owen C, Burvill-Holmes L, Stumper O, Turnpenny PD. 2007. Alagille syndrome with deletion 20p12.2-p12.3 and hypoplastic left heart. Clin Dysmorphol 16: 241-246.
22. Schutte BC, Murray JC. 1999. The many faces and factors of orofacial clefts. Hum Mol Genet 8: 1853-1859.
23. Shaffer LG, McCaskill C, Han JY, Choo KH, Cutillo DM, Donnenfeld AE, Weiss L, Van Dyke DL. 1994. Molecular characterization of de novo secondary trisomy 13. Am J Hum Genet 55: 968-974.
24. Spritz RA. 2001. The genetics and epigenetics of orofacial clefts. Curr Opin Pediatr 13: 556-560.
25. Stanier P, Moore GE. 2004. Genetics of cleft lip and palate: syndromic genes contribute to the incidence of non-syndromic clefts. Hum Mol Genet 13 Spec No 1: R73-R81.
26. van den Boogaard MJ, Dorland M, Beemer FA, van Amstel HK. 2000. MSX1 mutation is associated with orofacial clefting and tooth agenesis in humans. Nat Genet 24: 342-343.
27. Wan M, Cao X. 2005. BMP signaling in skeletal development. Biochem Biophys Res Commun 328: 651-657.
28. Zhang H, Bradley A. 1996. Mice deficient for BMP2 are nonviable and have defects in amnion/chorion and cardiac development. Development 122: 2977-2986.
29. Zhang Z, Song Y, Zhao X, Zhang X, Fermin C, Chen Y. 2002. Rescue of cleft palate in Msx1-deficient mice by transgenic Bmp4 reveals a network of BMP and Shh signaling in the regulation of mammalian palatogenesis. Development 129: 4135-4146.